NCT03470051 (EVALUATE) is a clinical trial of QT Ultrasound in Breast Fibroadenoma, sponsored by QT Ultrasound LLC.

Who is sponsoring NCT03470051?

NCT03470051 is sponsored by QT Ultrasound LLC.

What drugs are being tested in NCT03470051?

Interventions in NCT03470051: QT Ultrasound.

What condition does NCT03470051 study?

NCT03470051 studies Breast Fibroadenoma.

Is NCT03470051 still recruiting?

NCT03470051 is currently completed. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT03470051: EVALUATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology

Completed Last updated 18 March 2021

What this trial tests

trial testing QT Ultrasound in Breast Fibroadenoma in 27 participants. Completed in 11 February 2020.

Timeline

26 February 2018

Primary endpoint
11 February 2020

11 February 2020

Quick facts

Lead sponsor	QT Ultrasound LLC
Status	Completed
Study type	OBSERVATIONAL
Enrollment	27
Start date	26 February 2018
Primary completion	11 February 2020
Estimated completion	11 February 2020
Sites	2 locations across United States

Drugs / interventions tested

QT Ultrasound

Conditions studied

Breast Fibroadenoma — all drugs for Breast Fibroadenoma →

Sponsor

QT Ultrasound LLC

Who can join

18 and older, female only, with Breast Fibroadenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective case collection study to collect cases for subsequent statistical studies and future reader studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Fibroadenoma

Currently open trials in the same condition.

NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting

Other QT Ultrasound LLC trials

Trials by the same sponsor.

NCT04057391 — Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography · suspended
NCT03052166 — Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03470051 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by QT Ultrasound LLC
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03470051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing